The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy of envafolimab combined with capecitabine and lenvatinib as postoperative adjuvant therapy for radical resected cholangiocarcinoma with high-risk recurrence factors: A phase II single-center prospective study.
 
Mingyu Chen
No Relationships to Disclose
 
Yitong Tian
No Relationships to Disclose
 
Tianao Xie
No Relationships to Disclose
 
Ruijing Shen
No Relationships to Disclose
 
Xiujun Cai
No Relationships to Disclose